HR 4752
Reducing Hereditary Cancer Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 3:00 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Reducing Hereditary Cancer Act aims to improve access to care for individuals with a family history of hereditary cancer. It expands Medicare coverage to include germline mutation testing for those with a personal or family history of such mutations, as well as for risk-reducing surgeries and screenings. The bill also increases the frequency of evidence-based screenings, like mammograms and colonoscopies, for individuals identified as having a hereditary cancer gene mutation, aligning with established clinical guidelines.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.